Knee OsteoarthritismGAMENCT05652270
Maximizing Patient Goal Attainment
A study testing Goal Attainment, Goal Development and Goal Tracking in people with Knee Osteoarthritis and Knee Injuries, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.
Trial summary
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment. Read more about this study
- Who is it for?
- Ages 21 years and older
- Conditions the study is for
- Knee Osteoarthritis, Knee Injuries, Knee Pain Chronic
- What is being tested?
- Goal Attainment, Goal Development and Goal Tracking
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 258 participants
- Where
- 1 siteUnited States
- Study dates
- 30 May 2023to 4 Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Individuals 21 years of age or older
- New patients or existing patients with a new problem that are scheduled to see an orthopaedic surgeon in the Hip and Knee Arthroplasty service for a knee consult.
Who cannot join
- Individuals who are unable to consent or complete surveys without assistance
- Non-English speaking
- Patients who are less than 12 months from surgery on the knee they are being evaluated for, less than 6 months from surgery on the spine, or less than 3 months from another knee/hip surgery
Trial locations and contacts
1 site in 1 country.
United States1 site
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756
About this study
Official title: Maximizing Patient Goal Attainment, Motivations and Expectations (mGAME) in Elective Musculoskeletal Care
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.
- Being tested
- Goal Attainment, Goal Development, Goal Tracking
- Keywords
- Orthopaedic, Knee, Patient Goals
- Medical subject headings
- Osteoarthritis, Knee, Knee Injuries, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Goal AttainmentBehavioural
Development of an attainable goal
Goal DevelopmentBehavioural
A Systematic process to help patients create "SMaRT " goals
Goal TrackingBehavioural
Setting milestones to allow patients to track their progress towards their developed goal
| Study group | Role | What they receive |
|---|---|---|
| Goal Attainment Intervention | Active comparator | Not described Receives: Behavioral: Goal Attainment |
| Goal Development Intervention | Active comparator | Not described Receives: Behavioral: Goal Development |
| Goal Development and Tracking Intervention | Active comparator | Not described Receives: Behavioral: Goal Development; Behavioral: Goal Tracking |
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.
Measured: 8 Months
Secondary outcomes (1)
To assess the intervention's ability to improve shared decision making using the collaboRATE measure
To assess the acceptability, usability, as well as qualitatively the appropriateness, feasibility, and scalability of integrating the brief patient goal development intervention into standard clinical care. To assess the intervention's ability to improve shared decision making.
Measured: 8 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2022
- Study start30 May 2023
- Primary completion30 Nov 2026 (estimated)
- Study completion4 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Knee OsteoarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 258 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- Medacta USA
- Responsible party
- Principal investigator, Kevin.J.McGuire, Dartmouth-Hitchcock Medical Center
- Investigators
- Kevin J McGuire, MD, Principal investigator, Dartmouth-Hitchcock Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05652270
- Sponsor's protocol ID
- STUDY02001760
- Acronym
- mGAME
- Status last verified
- Mar 2026
- First submitted
- 7 Dec 2022
- Last updated
- 31 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Maximizing Patient Goal Attainment, Motivations and Expectations (mGAME) in Elective Musculoskeletal Care
- ClinicalTrials.gov ID
- NCT05652270
- Acronym / sponsor ID
- mGAME / STUDY02001760
- Keywords
- Orthopaedic, Knee, Patient Goals
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 258 participants (actual)
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterUniversity, hospital or other
- Collaborators
- Medacta USA
- Study start
- 30 May 2023 (actual)
- Primary completion
- 30 Nov 2026 (estimated)
- Study completion
- 4 Feb 2027 (estimated)
- First posted
- 15 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Goal Attainment Intervention | Active comparator | Behavioral: Goal Attainment |
| Goal Development Intervention | Active comparator | Behavioral: Goal Development |
| Goal Development and Tracking Intervention | Active comparator | Behavioral: Goal Development, Behavioral: Goal Tracking |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Individuals 21 years of age or older
- New patients or existing patients with a new problem that are scheduled to see an orthopaedic surgeon in the Hip and Knee Arthroplasty service for a knee consult.
Key exclusion criteria (3 listed)
- Individuals who are unable to consent or complete surveys without assistance
- Non-English speaking
- Patients who are less than 12 months from surgery on the knee they are being evaluated for, less than 6 months from surgery on the spine, or less than 3 months from another knee/hip surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Goal AttainmentDevelopment of an attainable goal | Behavioural | Goal Attainment Intervention |
| Goal DevelopmentA Systematic process to help patients create "SMaRT " goals | Behavioural | Goal Development Intervention, Goal Development and Tracking Intervention |
| Goal TrackingSetting milestones to allow patients to track their progress towards their developed goal | Behavioural | Goal Development and Tracking Intervention |
Primary outcome
To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure
Time frame: 8 Months
To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.
1 secondary outcome
To assess the intervention's ability to improve shared decision making using the collaboRATE measure
Time frame: 8 Months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Knee Osteoarthritis
Recruiting
Outpatient Physiotherapy vs. mHealth Exercise and Self-Management for Knee Osteoarthritis (MOKneeTOR)
Knee Osteoarthristis
Not yet recruiting
Effects of Music During Walking on Pain and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis
Knee Osteoarthritis
Recruiting
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
Osteoarthritis, Knee
Not yet recruiting
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
Knee Arthroplasty, Total, Partial Knee Arthroplasty
Not yet recruiting
Effects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis.(BFR)
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kevin J McGuire, MD principal investigator
Dartmouth-Hitchcock Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Goal Attainment, Goal Development and Goal Tracking in people with Knee Osteoarthritis and Knee Injuries, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure (time frame: 8 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.